ALK translocation and crizotinib in non-small cell lung cancer: An evolving paradigm in oncology drug development

2012 ◽  
Vol 48 (7) ◽  
pp. 961-973 ◽  
Author(s):  
Giorgio Scagliotti ◽  
Rolf A. Stahel ◽  
Rafael Rosell ◽  
Nick Thatcher ◽  
Jean-Charles Soria
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Small Cell ◽  
Small Cell Lung ◽  
Oncology Drug ◽  
Oncology Drug Development

scholarly journals Circulating tumor cell eXplants (CDX) to advance small cell lung cancer (SCLC) research and drug development

2016 ◽  
Vol 11 (2) ◽  
pp. S3
Author(s):  
Caroline Dive ◽  
Kris Frese ◽  
Ged Brady ◽  
Jonathan Tugwood ◽  
Crispin Miller ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Tumor Cell ◽  
Small Cell Lung Cancer ◽  
Cell Lung Cancer ◽  
Circulating Tumor Cell ◽  
Small Cell ◽  
Small Cell Lung

RFS2000 (9-nitrocamptothecin) in advanced small cell lung cancer, a phase II study of the EORTC New Drug Development Group

2004 ◽  
Vol 40 (9) ◽  
pp. 1332-1334 ◽  
Author(s):  
C.J.A. Punt ◽  
M.J.A. de Jonge ◽  
S. Monfardini ◽  
G. Daugaard ◽  
W. Fiedler ◽  
...  
Keyword(s):  
Lung Cancer ◽  
Drug Development ◽  
Small Cell Lung Cancer ◽  
Phase Ii ◽  
Cell Lung Cancer ◽  
Phase Ii Study ◽  
Small Cell ◽  
Small Cell Lung ◽  
New Drug Development ◽  
Development Group
Sign in / Sign up

Export Citation Format

Share Document